The Filing Desk

Grail vs GeneDx

Grail GRAL · GeneDx WGS · Health Care Services

GeneDx reported revenue of $428 million in fiscal 2025, 2.9 times Grail's $147 million in fiscal 2025. Grail's revenue grew 17.2% in its latest year, and GeneDx's grew 40.0%. Grail had an operating margin of -382.0%, against -3.1% at GeneDx. Free cash flow was −$300 million at Grail and $14 million at GeneDx.

Side by side

GrailGeneDx
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$147M$428M
Revenue growth17.2%40.0%
Revenue growth a year, last 5 years—19.0%
Gross margin—69.7%
Operating margin−382.0%−3.1%
Net margin−277.5%−4.9%
Free cash flow−$300M$14M
Free cash flow margin−203.8%3.3%
Return on capital—−5.3%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count15.2%6.5%
Last close$115.89$52.37
P/E at the last close——
Insider trades, last 12 monthssold $110.6 millionbought $106.6 million, sold $21.5 million
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
GrailGeneDx
Operating margin
Percent of revenue
GrailGeneDx
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
GrailGeneDx

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Grail and GeneDx pages.